Spots Global Cancer Trial Database for cord blood transplantation
Every month we try and update this database with for cord blood transplantation cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Safety and Efficacy of Unrelated Cord Blood Transplantation for Adult Patients With Hematologic Malignancies | NCT00270881 | Acute Myelogeno... Acute Lymphobla... Chronic Myeloge... Myelodysplastic... | Cord blood tran... TBI cyclophosphamid... cytarabine | 20 Years - 55 Years | Keio University | |
| Cellular Therapy With Cord Blood Cells | NCT00427557 | Multiple Myelom... Leukemia Lymphoma | Fludarabine Melphalan Umbilical Cord ... Rituximab Peripheral Bloo... | - 80 Years | M.D. Anderson Cancer Center | |
| Cellular Therapy With Cord Blood Cells | NCT00427557 | Multiple Myelom... Leukemia Lymphoma | Fludarabine Melphalan Umbilical Cord ... Rituximab Peripheral Bloo... | - 80 Years | M.D. Anderson Cancer Center | |
| Pilot Study Evaluating Safety & Efficacy of DCBT: NiCord® & UNM CBU to Patients With Hematological Malignancies | NCT01221857 | Acute Lymphobla... Acute Myelogeno... Myelodysplastic... Non-Hodgkin's L... Hodgkin's Disea... | NiCord® | 8 Years - 65 Years | Gamida Cell ltd | |
| Safety and Efficacy of Unrelated Cord Blood Transplantation for Adult Patients With Hematologic Malignancies | NCT00270881 | Acute Myelogeno... Acute Lymphobla... Chronic Myeloge... Myelodysplastic... | Cord blood tran... TBI cyclophosphamid... cytarabine | 20 Years - 55 Years | Keio University | |
| Eltrombopag for Enhancing Platelet Engraftment in Adult Patients Undergoing Cord Blood Transplantation | NCT01757145 | Hematological M... Bone Marrow Fai... | Eltrombopag | 18 Years - | Rabin Medical Center | |
| Unrelated Umbilical Cord Blood Transplantation With Coinfusion of Mesenchymal Stem Cells | NCT01092026 | Allogeneic Stem... | cord blood tran... | 15 Years - 60 Years | Universitair Ziekenhuis Brussel | |
| Study of Reduced Toxicity Myeloablative Conditioning Regimen for Cord Blood Transplantation in Pediatric AML | NCT00887042 | Acute Myeloid L... | Fludarabine, Bu... | 1 Year - 21 Years | The Korean Society of Pediatric Hematology Oncology | |
| Reduction of Cord Blood Transplantation Toxicity in Patients With Acute Myeloid Leukemia | NCT00797758 | Acute Myeloid L... | Cord blood tran... | 4 Years - 65 Years | Assistance Publique - Hôpitaux de Paris | |
| Adult Double Cord Blood Transplant Study | NCT00514579 | Cord Blood Stem... Hematologic Mal... | Cord blood tran... | 22 Years - 50 Years | Center for International Blood and Marrow Transplant Research | |
| Reduction of Cord Blood Transplantation Toxicity in Patients With Acute Myeloid Leukemia | NCT00797758 | Acute Myeloid L... | Cord blood tran... | 4 Years - 65 Years | Assistance Publique - Hôpitaux de Paris | |
| Safety and Efficacy of Unrelated Cord Blood Transplantation for Adult Patients With Hematologic Malignancies | NCT00270881 | Acute Myelogeno... Acute Lymphobla... Chronic Myeloge... Myelodysplastic... | Cord blood tran... TBI cyclophosphamid... cytarabine | 20 Years - 55 Years | Keio University | |
| Pilot Study Evaluating Safety & Efficacy of DCBT: NiCord® & UNM CBU to Patients With Hematological Malignancies | NCT01221857 | Acute Lymphobla... Acute Myelogeno... Myelodysplastic... Non-Hodgkin's L... Hodgkin's Disea... | NiCord® | 8 Years - 65 Years | Gamida Cell ltd | |
| Unrelated Umbilical Cord Blood Transplantation With Coinfusion of Mesenchymal Stem Cells | NCT01092026 | Allogeneic Stem... | cord blood tran... | 15 Years - 60 Years | Universitair Ziekenhuis Brussel | |
| Adult Double Cord Blood Transplant Study | NCT00514579 | Cord Blood Stem... Hematologic Mal... | Cord blood tran... | 22 Years - 50 Years | Center for International Blood and Marrow Transplant Research | |
| Safety and Efficacy of Unrelated Cord Blood Transplantation for Adult Patients With Hematologic Malignancies | NCT00270881 | Acute Myelogeno... Acute Lymphobla... Chronic Myeloge... Myelodysplastic... | Cord blood tran... TBI cyclophosphamid... cytarabine | 20 Years - 55 Years | Keio University | |
| Cord Blood Transplantation With Myeloablative Conditioning and Post-transplant Cyclophosphamide (COmPACt Study) | NCT03802773 | Cord Blood Tran... Hematological M... | CB transplantat... | 18 Years - 75 Years | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | |
| Cord Blood Transplantation in Patients With Advanced Lymphoid Malignancies | NCT01966510 | Patients With A... | Cord Blood Tran... | 18 Years - 65 Years | Assistance Publique - Hôpitaux de Paris | |
| Study of Reduced Toxicity Myeloablative Conditioning Regimen for Cord Blood Transplantation in Pediatric AML | NCT00887042 | Acute Myeloid L... | Fludarabine, Bu... | 1 Year - 21 Years | The Korean Society of Pediatric Hematology Oncology | |
| New York Blood Center National Cord Blood Program | NCT00212407 | Leukemia Lymphoma Genetic Disease Severe Aplastic... Myelodysplasia | Umbilical Cord ... | - | New York Blood Center | |
| Cord Blood With T-Cell Depleted Haplo-identical Peripheral Blood Stem Cell Transplantation for Hematological Malignancies | NCT01682226 | Leukemia Myelodysplastic... Lymphoma | CliniMACS Fract... CliniMACS Fract... Haploidentical ... | 2 Years - 70 Years | Memorial Sloan Kettering Cancer Center |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
